LanzaTech Global, Inc. — FY 2022 Form 10-K Summary
Reporting period: Fiscal year ended December 31, 2022; filed March 28, 2023. LanzaTech converts waste gases and other waste carbon into ethanol and other products through gas fermentation, earning revenue primarily through licensing, engineering and services, royalties, and supplies. Its securities trade on Nasdaq as LNZA and LNZAW.
Important scope limitation: The Business Combination closed on February 8, 2023, after the reporting period. The audited financial statements and MD&A in this 10-K are for AMCI Acquisition Corp. II, the former blank-check company—not Legacy LanzaTech’s operating business. The filing says Legacy LanzaTech’s audited 2022 financial statements and related MD&A were to be provided in a separate Form 8-K/A.
Business and operating context
- Three commercial plants in China were operating using LanzaTech technology. They had cumulatively produced more than 54 million gallons of fuel-grade ethanol and mitigated more than 275,000 tons of CO₂ since operations began in 2018.
- Twelve additional commercial facilities were under construction or development: four in construction and eight in engineering. Timing and completion remain dependent on partners, financing, construction, permitting, and project economics.
- Demonstration or smaller-scale facilities in Canada and Japan completed commissioning or began operations in 2022. The company also reported commercial projects in Belgium and India progressing toward startup.
- LanzaTech held approximately 25% of LanzaJet, which was developing a 10-million-gallon-per-year sustainable aviation fuel and renewable diesel facility in Georgia. Completion was expected in 2023, but was not assured.
Financial results and liquidity
| Metric | What the filing reports |
|---|---|
| Revenue and margins | The audited statements included here report no operating revenue for AMCI before the Business Combination. They do not provide Legacy LanzaTech’s 2022 revenue or margins; consult the referenced Form 8-K/A. |
| Legacy LanzaTech losses | The risk factors report net losses after tax of approximately $76.4 million in 2022 and $46.7 million in 2021, with an accumulated deficit of $456.2 million at December 31, 2022. The filing does not include the operating-company statements supporting these figures in this 10-K. |
| AMCI net loss | $1.36 million for 2022, versus net income of $47,000 from inception on January 28, 2021 through December 31, 2021. The 2021 period is not a full-year comparable. |
| AMCI cash flow | Net cash used in operating activities was $346,000 in 2022. The audited cash-flow statement does not provide Legacy LanzaTech’s cash flows. |
| AMCI year-end liquidity | At December 31, 2022, AMCI had $6,671 in operating cash, $152.3 million in trust-account investments, and a working-capital deficit of approximately $5.9 million. These are pre-combination AMCI figures, not a post-combination LanzaTech balance sheet. |
| Capital raised at closing | The PIPE investment totaled $185 million. The company reported retaining approximately $153 million, net of transaction expenses, as working capital after the Business Combination. |
| Debt and other obligations | No consolidated post-combination debt balance is clearly provided in this 10-K. LanzaTech committed to purchase $5.5 million of LanzaJet subordinated secured notes, with funding expected May 1, 2023. A separate $50 million Brookfield SAFE may convert into stock or require repayment, with high-single-digit compounded interest on any remaining amount at its fifth anniversary, subject to reductions tied to qualifying project funding. |
AMCI’s 2022 results included a $3.0 million gain from changes in warrant-liability fair value and $2.3 million of trust investment income, partly offset by $5.9 million of general and administrative expense. These non-operating and transaction-related items are not measures of LanzaTech’s operating performance.
Changes, outlook, risks, and unusual items
- The February 2023 Business Combination transformed the former SPAC into the public holding company for Legacy LanzaTech. The financial statements in this filing do not present a full-year combined operating-company comparison.
- Management stated that cash and cash equivalents were expected to fund operations for at least 12 months from the report date, and that post-combination working capital and borrowing capacity were expected to meet needs for one year. This is management’s assessment, not a guarantee.
- The filing gives no quantified consolidated revenue or earnings guidance. Management’s business outlook depends on building and commissioning partner-owned plants, increasing recurring licensing and royalty revenue, reducing facility costs, and scaling new products and feedstocks.
- The company has not achieved operating profitability and expects continuing losses until its technologies are sufficiently commercialized. It warns that it may need substantial additional financing.
- Key risks include project delays and cost overruns; dependence on a limited number of partners; variable feedstock availability and economics; competition from fossil-derived products; uncertainty in low-carbon fuel incentives and regulation; and exposure to China-related political, regulatory, and trade risks.
- Management reported ineffective disclosure controls at December 31, 2022 due to a material weakness involving agreement interpretation and disclosure and deferred-tax accounting. The filing also describes Legacy LanzaTech control weaknesses and restatements of previously issued 2020 and 2021 financial statements. Management was working on remediation; the auditor did not attest to internal-control effectiveness.
- Other notable arrangements include Brookfield’s project-investment framework, which is not a commitment by Brookfield to fund projects, and the exclusive, royalty-free license of certain ethanol-to-fuel intellectual property to LanzaJet.
- The company reported no legal proceedings believed likely to have a material effect on its consolidated financial position or liquidity. It does not anticipate cash dividends in the foreseeable future.
Most important facts for investors to verify
- Review the referenced Form 8-K/A for Legacy LanzaTech’s audited 2022 financial statements, revenue, cash flow, liquidity, debt, and comparable-period results.
- Reconcile the reported $153 million of post-combination working capital with subsequent cash use, capital commitments, and financing needs.
- Track construction, commissioning, capacity, and actual production at the 12 projects in development, as well as the Georgia SAF facility’s completion and financing.
- Assess whether commercial plants generate the royalties, licensing fees, and services revenue needed to reduce losses, and whether plant economics remain competitive.
- Monitor remediation of internal-control weaknesses and any further restatements or reporting delays.
- Review potential dilution and repayment exposure from warrants, equity plans, the Brookfield SAFE, and the LanzaJet note commitment.